Nevertheless, our results suggest that epigenetic alterations in gliomas caused by the IDH1 mutation could be one of the mechanisms of action underlying the distinct immunological features between IDH1-mutant and wildtype tumors. The gene discussed is IDH1; the disease is central nervous system cancer.